Fundraising Fox
BioNTech
Mainz, DE · Founded 2008 · 7 known investors
Find your way into BioNTech
Sign up to see every warm intro you have to BioNTech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioNTech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioNTech is a biotechnology company developing immunotherapies that use the body's immune system, combining multiple therapeutic modalities and biological targets to treat cancer, infectious diseases, and other serious conditions. It operates globally in the pharmaceutical and biotech industry.
Founders & leadership
BioNTech was founded in 2008 by Ozlem Tureci and Ugur Sahin.
Board
Investors · 7
How we know: Manta Ray Ventures's portfolio page · Not right? Tell us
How we know: MIG Capital AG's portfolio page · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Onsight Ventures's portfolio page · Not right? Tell us
Funding
SEC filings, press & company announcements$400M disclosed across 2 of 6 rounds · 2019–2026
▶$150MraisedApr 2022 · 1 investors · BiotechnologyRule 506(b)
- Ryan RichardsonExecutive Officer
- Ugur SahinExecutive Officer
- Michael MotschmannDirector
- Sierk PoettingExecutive Officer
- Christoph HuberDirector
- Jens HolsteinExecutive Officer
- Ozlem TureciExecutive Officer
- Ulrich WandschneiderDirector
- Sean MarettExecutive Officer
- Helmut JeggleDirector
- Offering amount
- $150M
- Amount sold
- $150M
- First sale
- Apr 2022
- Incorporated
- Corporation, Germany
- Federal exemptions
- 06b
▶$250MraisedSep 2020 · 2 investors · BiotechnologyRule 506(b)
- Sierk PoettingExecutive Officer
- Sean MarettExecutive Officer
- Ulrich WandschneiderDirector
- Christoph HuberDirector
- Ozlem TureciExecutive Officer
- Michael MotschmannDirector
- Ugur SahinExecutive Officer
- Helmut JeggleDirector
- Ryan RichardsonExecutive Officer
- Offering amount
- $250M
- Amount sold
- $250M
- First sale
- Sep 2020
- Incorporated
- Corporation, Germany
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does BioNTech do?
- BioNTech is a biotechnology company developing immunotherapies that use the body's immune system, combining multiple therapeutic modalities and biological targets to treat cancer, infectious diseases, and other serious conditions. It operates globally in the pharmaceutical and biotech industry.
- Who founded BioNTech?
- BioNTech was founded by Ozlem Tureci, Ugur Sahin in 2008.
- Who are BioNTech's investors?
- BioNTech's investors include HM Venture Partners, Manta Ray Ventures, MIG Capital AG, Onsight Ventures, Pfizer Venture Investments, Salvia, Andreessen Horowitz.
- How much funding has BioNTech raised?
- BioNTech has disclosed $400M raised across 2 of its 6 known rounds.
- Where is BioNTech headquartered?
- BioNTech is headquartered in Mainz, DE.